Trending News

Altimmune (ALT) fell 27% despite release positive clinical data in their non-alcoholic fatty liver disease (NAFLD) trial. Altimmune’s drug candidate reached its primary endpoint of a significant reduction in liver fat across all dose groups, as well as their secondary endpoint, of mean weight losses of 4.9% in patients without diabetes and 4.4% in patients… [Read More]

 Benitec Biopharma (BNTC) fell 28% for the day to $0.45 per share, with a the decline in share price largely cancels out BNTC’s earlier gains from their year-long financial results. Benitec has recently announced that they have priced an $18M public offering. Per their press release, “the Company intends to use the net proceeds from… [Read More]

Bristol Myers Squibb   BMY (NYSE) 2019 acquisition of Celgene continues to pay dividends. At the time, Bristol Myers Squibb chose to keep deucravacitinib, instead of the approved Otezla, as a potential treatment for moderate-to-severe plaque psoriasis. (Otezla is now owned by Amgen.) The drug, now known as Soyuktu  recently earned FDA approval and Bristol… [Read More]

Bentic Biopharma (BNTC) is up 33% for the day, following their 2022 financial results and operational update. “We continue to move closer to the initiation of the clinical evaluation of BB-301,” said Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec Biopharma. “The Benitec team remains committed to improving the lives… [Read More]

Pilbara Minerals (PILBF) is up 14.41% for the day, largely due to JP Morgans positive broker upgrade. Pilbara is also benefiting from strong lithium prices. The analyst Lydon Fagan upgraded PILBF to an outperform rating and gave the Company a price target of $4.10. A key reason for the upgrade is long-term estimates in lithium… [Read More]

HIVE announced that they approved the grant of 415,200 incentive stock options exercisable into the equivalent amount of common shares priced C$5.66 per share for a period of five years. The grants were made to employees, officers and consultants of the Company, encouraging them to continue their significant contributions to the Company, while also allowing… [Read More]

The PRISM Uranium Index soared 16% today on speculations of high demand for Uranium. Japan has called for a study of new nuclear plants, raising hopes of a resurgence in uranium. The Japanese Prime Minister Fumio Kishida also said he wanted a government committee to consider building new nuclear-powerplants. In addition, Germany has postponed the… [Read More]

Applied DNA Sciences (APDN) jumped 14% today, based on the news that they have submitted a PCR-based Monkeypox Diagnostic Test for approval to the New York State Department of Health. The test is named the Linea Monkeypox Virus 1.0 Assay and would be Applied DNA’s second successful Lab Developed Test in less than one year… [Read More]

IonQ, Inc. (IONQ) rose 32% on the announcement that IonQ Aria is now available on the Azure Quantum Platform. Users from around the world can now access one of the most powerful quantum systems, paving the way for new quantum applications. “Having IonQ Aria be available to Azure Quantum customers is exciting, as it aligns… [Read More]

Canopy Growth Corporation (CGC) rose almost 16% for the day on positive news of Cannabis as a whole. Two stories stood out today. Firstly, New York Marijuana regulators have approved  15 licenses to New York businesses, bringing NY one step closer to selling recreational marijuana. These processors are the first to be able to take… [Read More]